ENHANCEMENT BY THE D1 DOPAMINE AGONIST SKF-38393 OF SPECIFIC COMPONENTS OF STEREOTYPY ELICITED BY THE D2 AGONISTS LY-171555 AND RU-24213

被引：42

|

作者：

MELLER, E

BORDI, F

BOHMAKER, K

机构：

来源：

LIFE SCIENCES | 1988年 / 42卷 / 25期

关键词：

D O I：

10.1016/0024-3205(88)90324-4

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

收藏

页码：2561 / 2657

页数：97

相关论文

共 45 条

[31] HYPERTENSIVE DOCA/NACL RATS EXHIBIT REDUCED PRESSOR-RESPONSE TO THE SPECIFIC DOPAMINE (D2) AGONIST, LY171555
CHEN, YF
NAGAHAMA, S
OPARIL, S
CLINICAL RESEARCH, 1986, 34 (01): : A188 - A188
[32] THE EFFECTS OF CLOZAPINE ON BEHAVIORAL-RESPONSES TO THE SELECTIVE D-1-LIKE DOPAMINE-RECEPTOR AGONIST, A-68930, AND TO THE SELECTIVE D-2-LIKE AGONIST, RU-24213
DALY, SA
WADDINGTON, JL
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 113 (03) : 839 - 844
[33] STIMULATION OF POSTSYNAPTIC D2-DOPAMINE RECEPTORS BY B-HT-958 IS REVEALED BY CO-TREATMENT WITH THE D1-RECEPTOR AGONIST SKF-38393
ANDEN, NE
GRABOWSKAANDEN, M
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1989, 41 (07) : 490 - 492
[34] Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene are in prefrontal cortex of rats
Moro, Hiroomi
Sato, Hirohito
Ida, Itsurou
Oshima, Akihiko
Sakurai, Noriko
Shihara, Nobuyuki
Horikawa, Yukio
Mikuni, Masahiko
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2007, 87 (01) : 56 - 64
[35] AUTORADIOGRAPHIC DISTRIBUTION OF THE D1 AGONIST [H-3] SKF 38393, IN THE RAT-BRAIN AND SPINAL-CORD - COMPARISON WITH THE DISTRIBUTION OF D2 DOPAMINE-RECEPTORS
DUBOIS, A
SAVASTA, M
CURET, O
SCATTON, B
NEUROSCIENCE, 1986, 19 (01) : 125 - &
[36] Repeated treatments with the D1 dopamine receptor agonist SKF-38393 modulate cell viability via sustained ERK-Bad-Bax activation in dopaminergic neuronal cells
Park, Hyun Jin
Zhao, Ting Ting
Park, Keun Hong
Lee, Myung Koo
BEHAVIOURAL BRAIN RESEARCH, 2019, 367 : 166 - 175
[37] GROOMING IN THE MOUSE IS STIMULATED BY THE DOPAMINE D1-AGONIST SKF-38393 AND BY LOW-DOSES OF THE D1-ANTAGONIST SCH-23390, BUT IS INHIBITED BY DOPAMINE D2-AGONISTS, D2-ANTAGONISTS AND HIGH-DOSES OF SCH-23390
STARR, BS
STARR, MS
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1986, 24 (04) : 837 - 839
[38] DIFFERENTIAL INVOLVEMENT OF DOPAMINE D-1 AND D-2 RECEPTORS IN THE CIRCLING BEHAVIOR INDUCED BY APOMORPHINE, SK+F-38393, PERGOLIDE AND LY-171555 IN 6-HYDROXYDOPAMINE-LESIONED RATS
ARNT, J
HYTTEL, J
PSYCHOPHARMACOLOGY, 1985, 85 (03) : 346 - 352
[39] Effects of full D1 dopamine receptor agonists on firing rates in the globus pallidus and substantia nigra pars compacta in vivo:: Tests for D1 receptor selectivity and comparisons to the partial agonist SKF 38393
Ruskin, DN
Rawji, SS
Walters, JR
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1998, 286 (01): : 272 - 281
[40] SPECIFIC D1 AND D2 DOPAMINE AGONISTS HAVE SYNERGISTIC EFFECTS IN THE 6-HYDROXYDOPAMINE CIRCLING MODEL IN THE RAT
ROUILLARD, C
BEDARD, PJ
NEUROPHARMACOLOGY, 1988, 27 (12) : 1257 - 1264

← 1 2 3 4 5 →